BIOLASE Inc
NASDAQ:BIOL
BIOLASE Inc
NASDAQ:BIOL
Price:
0.1768 USD
21.85%
Market Closed
Updated:
May 7, 2024
BIOLASE Inc
Revenue
|
BIOLASE Inc
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BIOLASE Inc
NASDAQ:BIOL
|
Revenue
$49.2m
|
CAGR 3-Years
29%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
BIOLASE Inc
Revenue Breakdown
Breakdown by Geography
BIOLASE Inc
BIOLASE Inc
|
Total Revenue:
49.2m
USD
|
|
United States:
33.9m
USD
|
|
Non-Us:
15.3m
USD
|
Breakdown by Segments
BIOLASE Inc
BIOLASE Inc
|
Total Revenue:
49.2m
USD
|
|
Laser Systems:
30m
USD
|
|
Consumable And Other:
13.6m
USD
|
|
Service:
5.5m
USD
|
See Also
What is BIOLASE Inc's Revenue?
Revenue
49.2m
USD
49.2m
USD
Based on the financial report for Dec 31, 2023, BIOLASE Inc's Revenue amounts to 49.2m USD.
What is BIOLASE Inc's Revenue growth rate?
Revenue CAGR 10Y
-1%
-1%
Over the last year, the Revenue growth was 1%. The average annual Revenue growth rates for BIOLASE Inc have been 29% over the past three years , 1% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
